Page last updated: 2024-08-26

bismuth and lutetium

bismuth has been researched along with lutetium in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (7.14)18.2507
2000's6 (42.86)29.6817
2010's4 (28.57)24.3611
2020's3 (21.43)2.80

Authors

AuthorsStudies
Bauer, M; Krause, W; Muschick, P; Press, WR; Schuhmann-Giampieri, G1
Anderson, T; Atcher, R; Nayak, T; Norenberg, J1
Anderson, TL; Atcher, RW; Nayak, TK; Norenberg, JP; Prossnitz, ER; Stabin, MG1
Hosono, Y; Itsumi, K; Yamashita, Y1
Brady, ED; Brechbiel, MW; Chong, HS; Kwamena, B; Le, T; Ma, X; Milenic, DE; Song, HA1
David, S; Kandarakis, I; Michail, C; Nomicos, CD; Panayiotakis, GS; Valais, I1
Birch, N; Chong, HS; Le, T; Lim, S; Ma, X; Song, HA1
Beck, R; Bruchertseifer, F; Quintanilla-Martinez, L; Seidl, C; Senekowitsch-Schmidtke, R; Zöckler, C1
Boisclair, J; Bruchertseifer, F; Frischknecht, M; Maecke, HR; Morgenstern, A; Provencher-Bolliger, A; Reubi, JC; Wild, D; Zhang, H1
Breeman, W; Bruchertseifer, F; Chan, HS; de Blois, E; de Jong, M; Konijnenberg, M; Morgenstern, A1
Bednarz, B; Lee, D; Li, M; Schultz, MK1
Auffray, E; Gundacker, S; Kratochwil, N; Lecoq, P1
Allen, KJH; Dadachova, E; de Klerk, JMH; Helal, M; Lam, MGEH; van der Wal, BCH; van Dijk, B; Vogely, HC; Weinans, H1
Ariño-Estrada, G; Bai, X; Cherry, SR; Du, J1

Other Studies

14 other study(ies) available for bismuth and lutetium

ArticleYear
Ytterbium- and dysprosium-EOB-DTPA. A new prototype of liver-specific contrast agents for computed tomography.
    Investigative radiology, 1996, Volume: 31, Issue:8

    Topics: Animals; Biological Products; Bismuth; Bone and Bones; Cerium; Chelating Agents; Chemical Phenomena; Chemistry, Physical; Contrast Media; Dysprosium; Erythrocytes; Humans; Lanthanum; Lead; Liver; Lutetium; Minerals; Organometallic Compounds; Osmolar Concentration; Partial Thromboplastin Time; Pentetic Acid; Phantoms, Imaging; Praseodymium; Protein Binding; Rabbits; Radiographic Image Enhancement; Rats; Tissue Distribution; Tomography, X-Ray Computed; Viscosity; Ytterbium

1996
A comparison of high- versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro.
    Cancer biotherapy & radiopharmaceuticals, 2005, Volume: 20, Issue:1

    Topics: Actinium; Alpha Particles; Apoptosis; Beta Particles; Bismuth; Cell Line, Tumor; Cell Nucleus; Cell Survival; Dose-Response Relationship, Radiation; Energy Transfer; Enzyme-Linked Immunosorbent Assay; Humans; Ligands; Lutetium; Mitosis; Models, Statistical; Neoplasms; Octreotide; Radioisotopes; Radiometry; Radiopharmaceuticals; Receptors, Somatostatin

2005
Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.
    Nuclear medicine and biology, 2007, Volume: 34, Issue:2

    Topics: Adenocarcinoma; Alpha Particles; Beta Particles; Bismuth; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Radiation; Drug Delivery Systems; Humans; Lutetium; Pancreatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Receptors, Somatostatin; Treatment Outcome

2007
Effects of fine metal oxide particle dopant on the acoustic properties of silicone rubber lens for medical array probe.
    IEEE transactions on ultrasonics, ferroelectrics, and frequency control, 2007, Volume: 54, Issue:8

    Topics: Acoustics; Aluminum Oxide; Bismuth; Cerium; Equipment Design; Hafnium; Lutetium; Microscopy, Electron, Scanning; Nanoparticles; Oxides; Particle Size; Silicones; Surface Properties; Titanium; Ultrasonography; Ytterbium

2007
Rational design and generation of a bimodal bifunctional ligand for antibody-targeted radiation cancer therapy.
    Journal of medicinal chemistry, 2008, Jan-10, Volume: 51, Issue:1

    Topics: Animals; Antibodies; Bismuth; Chelating Agents; Drug Design; Drug Stability; Female; Glycine; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Kinetics; Ligands; Lutetium; Mice; Mice, Nude; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Serum; Spectrophotometry, Ultraviolet; Tissue Distribution

2008
A comparative study of the luminescence properties of LYSO:Ce, LSO:Ce, GSO:Ce and BGO single crystal scintillators for use in medical X-ray imaging.
    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2008, Volume: 24, Issue:2

    Topics: Biophysical Phenomena; Biophysics; Bismuth; Crystallization; Female; Gamma Cameras; Germanium; Humans; Luminescence; Lutetium; Mammography; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Silicates; Yttrium

2008
Efficient synthesis and evaluation of bimodal ligand NETA.
    Bioorganic & medicinal chemistry letters, 2008, Jun-01, Volume: 18, Issue:11

    Topics: Acetates; Bismuth; Chelating Agents; Crystallography, X-Ray; Drug Design; Heterocyclic Compounds; Kinetics; Ligands; Lutetium; Molecular Conformation; Molecular Structure; Radioimmunotherapy; Radioisotopes

2008
177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213Bi.
    European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Bismuth; Blood Cell Count; Cell Line, Tumor; Disease Models, Animal; Drug Stability; Female; Humans; Immunoconjugates; Lutetium; Mice; Peritoneal Neoplasms; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Stomach Neoplasms; Time Factors

2011
Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN).
    Cancer research, 2011, Feb-01, Volume: 71, Issue:3

    Topics: Alpha Particles; Animals; Beta Particles; Bismuth; Female; Humans; Lutetium; Male; Mice; Mice, Nude; Oligopeptides; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Xenograft Model Antitumor Assays

2011
In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapy.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Absorption, Radiation; Bismuth; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Radiation; Humans; Kinetics; Linear Energy Transfer; Lutetium; Models, Biological; Monte Carlo Method; Octreotide; Organometallic Compounds; Radioisotopes; Radiometry; Radiopharmaceuticals; Receptors, Somatostatin

2017
Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
    Radiation research, 2018, Volume: 190, Issue:3

    Topics: Actinium; Alpha Particles; Beta Particles; Bismuth; Dose-Response Relationship, Radiation; Humans; Lead Radioisotopes; Lutetium; Neoplasm Metastasis; Neoplasms; Radioisotopes; Yttrium Radioisotopes

2018
Pushing Cherenkov PET with BGO via coincidence time resolution classification and correction.
    Physics in medicine and biology, 2020, 06-05, Volume: 65, Issue:11

    Topics: Bismuth; Electronics; Germanium; Image Processing, Computer-Assisted; Lutetium; Photons; Positron-Emission Tomography; Scintillation Counting; Silicates

2020
Radioimmunotherapy of methicillin-resistant Staphylococcus aureus in planktonic state and biofilms.
    PloS one, 2020, Volume: 15, Issue:5

    Topics: Actinium; Antibodies, Monoclonal; Biofilms; Bismuth; Humans; In Vitro Techniques; Lutetium; Methicillin-Resistant Staphylococcus aureus; Plankton; Proof of Concept Study; Prosthesis-Related Infections; Radioimmunotherapy; Radioisotopes; Staphylococcal Infections; Teichoic Acids

2020
Performance comparison of dual-ended readout depth-encoding PET detectors based on BGO and LYSO crystals.
    Physics in medicine and biology, 2020, 11-27, Volume: 65, Issue:23

    Topics: Background Radiation; Bismuth; Germanium; Lutetium; Positron-Emission Tomography; Yttrium

2020